Skip to main content
. 2020 Aug 25;12(9):801. doi: 10.3390/pharmaceutics12090801

Figure 3.

Figure 3

Strategies for genome editing using the CRISPR/Cas9 technology. (A) plasmid-borne CRISPR/Cas9 system. (B) Cas9/sgRNA complex. (C) Cas9 mRNA and sgRNA mixture.